Press release
Connected Drug Delivery Devices Market is expected to reach USD 5.32 billion by 2034
Connected Drug Delivery Devices
Explore Full Report here: https://exactitudeconsultancy.com/request-sample/73439
They play a critical role in chronic disease management such as asthma, COPD, diabetes, multiple sclerosis, and oncology, ensuring improved adherence, real-time monitoring, and integration with digital health platforms.
The global market is expanding rapidly due to rising chronic disease burden, digital health adoption, patient-centric care models, and regulatory support for connected therapeutics.
Market Overview
• Market Size (2024): USD 1.45 billion
• Forecast (2034): USD 5.32 billion
• CAGR (2025-2034): 13.8%
Growth is driven by expanding smart inhaler and injector adoption, AI-driven adherence platforms, and integration with telehealth ecosystems.
Key Highlights:
• Non-adherence contributes to ~50% of chronic disease treatment failures, fueling demand.
• Smart inhalers dominate respiratory care; connected injectors expanding in diabetes and autoimmune disorders.
• AI-based platforms improve dosing accuracy and predict adherence risks.
• Pharma companies partnering with digital health firms to launch integrated therapeutic ecosystems.
Segmentation Analysis
By Product Type:
• Connected Inhalers
o Metered-Dose Inhalers (MDIs)
o Dry Powder Inhalers (DPIs)
o Nebulizers
• Connected Injectors
o Auto-Injectors (for biologics, rheumatoid arthritis, MS, oncology)
o Insulin Pens & Pumps
o Wearable Injectors (patch pumps, on-body delivery systems)
• Connected Wearables & Others
o Digital Pills & Sensors
o Smart Pill Bottles & Packaging
By Technology:
• Bluetooth & Wireless Connectivity
• AI & Machine Learning Adherence Platforms
• Cloud-Based Remote Monitoring Systems
• Mobile App Integration & Analytics
By End Use:
• Hospitals & Specialty Clinics
• Home Healthcare & Self-Administration
• Pharmaceutical & Biotech Companies (companion device programs)
• Research Institutes
By Application:
• Respiratory Diseases (asthma, COPD)
• Diabetes Management
• Autoimmune Disorders (RA, MS, psoriasis)
• Oncology (biologics, immunotherapies)
• Others (cardiovascular, pain management)
Segmentation Summary:
Connected inhalers dominate respiratory care, while injectors and insulin pens are expanding fastest. Wearable injectors and digital pills represent emerging frontiers.
Explore Full Report here: https://exactitudeconsultancy.com/reports/73439/connected-drug-delivery-devices-market
Regional Analysis
North America
• ~40% share in 2024.
• Strong adoption of digital health platforms and smart devices.
• FDA support for connected therapeutics integration.
Europe
• ~32% share.
• EMA regulations encouraging digital adherence monitoring.
• High adoption in UK, Germany, and France.
Asia-Pacific
• Fastest-growing region with CAGR of ~15.1%.
• Rising prevalence of diabetes and respiratory diseases in India and China.
• Expanding telehealth and mobile health app usage.
Middle East & Africa
• Gradual adoption of connected devices with healthcare modernization.
• Limited affordability in low-income regions.
Latin America
• Brazil and Mexico leading connected drug delivery adoption.
• Growing partnerships between pharma and medtech firms.
Regional Summary:
North America and Europe dominate due to strong digital infrastructure and pharma collaborations, while Asia-Pacific grows fastest due to high disease burden and mobile health adoption.
Market Dynamics
Key Growth Drivers:
• Rising chronic disease burden (diabetes, asthma, COPD, autoimmune disorders).
• Increasing demand for personalized and digital health-integrated therapies.
• Pharma-medtech partnerships for companion devices.
• AI and mobile apps enhancing adherence and remote monitoring.
Key Challenges:
• High device and integration costs.
• Data privacy and cybersecurity concerns.
• Limited reimbursement for digital health-enabled devices.
• Patient adoption barriers in low-resource regions.
Latest Trends:
• Expansion of wearable injectors for biologics and oncology drugs.
• Smart inhalers integrated with real-time environmental triggers.
• Use of digital twins and AI models for personalized dosing.
• Growth of value-based care models with connected therapeutics.
Get Your Exclusive Offer with up to 10% Discount : https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=73439
Competitor Analysis
Major Players in the Market:
• Teva Pharmaceuticals (ProAir Digihaler - connected inhaler)
• AstraZeneca plc (smart inhaler partnerships)
• Propeller Health (acquired by ResMed - digital inhaler platforms)
• Novartis AG
• Adherium Limited (connected respiratory devices)
• Medtronic plc (connected insulin pumps)
• Insulet Corporation (Omnipod - wearable injectors)
• Dexcom, Inc. (glucose monitoring integrations)
• Phillips-Medisize (drug delivery device innovation)
• Bigfoot Biomedical (AI-powered diabetes solutions)
Competitive Summary:
Teva, AstraZeneca, and Propeller dominate connected inhalers. Medtronic, Insulet, and Bigfoot lead connected injectors. Partnerships between pharma (Novartis, GSK) and medtech firms are driving integrated connected ecosystems. Competition focuses on AI integration, wearable injectors, and companion device programs.
Conclusion
The Connected Drug Delivery Devices Market, valued at USD 1.45 billion in 2024, is projected to reach USD 5.32 billion by 2034, growing at a CAGR of 13.8%. Expanding smart inhalers, AI-enabled injectors, and digital therapeutic ecosystems will continue to drive growth.
Key Takeaways:
• Smart inhalers dominate today, injectors and wearables represent fastest-growing categories.
• North America and Europe lead adoption, while Asia-Pacific grows fastest.
• Pharma-medtech collaborations are reshaping therapeutic delivery.
• Future opportunities in AI-driven dosing, digital twins, and telehealth-integrated therapeutics.
The next decade will transform connected drug delivery from basic adherence tools to AI-driven, ecosystem-integrated therapeutic platforms, creating significant opportunities for pharma, medtech, and digital health innovators.
This report is also available in the following languages : Japanese (コネクテッドドラッグデリバリーデバイス市場), Korean (연결된 약물 전달 장치 시장), Chinese (联网药物输送设备市场), French (Marché des dispositifs connectés d'administration de médicaments), German (Markt für vernetzte Arzneimittelverabreichungsgeräte), and Italian (Mercato dei dispositivi di somministrazione di farmaci connessi), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/reports/73439/connected-drug-delivery-devices-market#request-a-sample
Our More Reports:
Drug Delivery Technologies Market
https://exactitudeconsultancy.com/reports/73481/drug-delivery-technologies-market
Prenatal Testing and Newborn Screening Market
https://exactitudeconsultancy.com/reports/73483/prenatal-testing-and-newborn-screening-market
Intraocular Pressure Devices Market
https://exactitudeconsultancy.com/reports/73485/intraocular-pressure-devices-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Connected Drug Delivery Devices Market is expected to reach USD 5.32 billion by 2034 here
News-ID: 4182624 • Views: …
More Releases from Exactitude Consultancy
Neurovascular Devices Market is expected to reach USD 6.89 billion by 2034
Neurovascular devices are specialized medical tools designed for the diagnosis and treatment of disorders affecting the brain's blood vessels, including ischemic stroke, hemorrhagic stroke, cerebral aneurysms, and arteriovenous malformations (AVMs). These devices include stent retrievers, embolic coils, flow diverters, and aspiration catheters, which have revolutionized stroke and aneurysm management.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/73441
The market is expanding due to rising stroke prevalence, rapid adoption of minimally…
Europe In Vitro Diagnostics (IVD) Market to Reach USD 43.6 Billion by 2034
In vitro diagnostics (IVD) refers to tests performed on blood, tissue, and other samples outside the human body to detect diseases, monitor health, and guide treatment. IVD plays a central role in early diagnosis, personalized medicine, and chronic disease management, covering areas such as oncology, infectious diseases, cardiology, and diabetes monitoring.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/73443
Europe has long been a global leader in IVD due to…
Medical Robotics Market to Surge to USD 61.3 Billion by 2034
Medical robotics refers to the use of robotic systems in healthcare applications, including surgery, rehabilitation, pharmacy automation, and hospital logistics. These robots enhance precision, reduce human error, shorten recovery times, and improve patient outcomes.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/73445
The market is undergoing rapid transformation due to advancements in AI, sensor technology, and minimally invasive procedures, alongside growing healthcare investments and rising demand for patient-centric care.
Market Overview
• Market…
Needles Market to Reach USD 14.7 Billion by 2034
Needles remain one of the most essential medical consumables worldwide, used in drug delivery, blood sampling, vaccination, and diagnostic procedures. Despite their simplicity, continuous innovation has led to safer, more efficient, and patient-friendly designs, including safety-engineered needles, pen needles, and microneedles.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/73447
The global needles market is expanding due to increasing demand for injectable drugs, growing vaccination programs, rising chronic disease burden (diabetes,…
More Releases for Connect
Guide to Connect Expedia Customer Service: 24/7 Live Expedia Phone Number| Fast …
Expedia is known for its excellent customer service, offering multiple ways to get assistance when needed. Whether you're looking for Expedia customer service 24 hours support +1-888 (349-5429), need to speak with a live person, or want to reach out via email, we've got you covered. In this article, we will guide you on how to contact Expedia customer service directly and efficiently.
Expedia Customer Service Phone Number
The fastest way to…
Connect Real Dating Introduces "Connect Map" - Revolutionizing Real-Time Sociali …
Connect Real Dating, the innovative dating app designed for real life connections, is excited to announce the launch of its latest feature, the "Connect Map". This game-changing tool is set to transform the way singles socialize, making it easier than ever to discover and connect with others in real time.
Imagine it's a Friday night, and you're ready to hit the town. Instead of guessing where everyone is gathering, the Connect…
Cross-Connect System Market
According to new research study on "Cross-Connect System Market," the report delivers comprehensive insights into the market's size, share, trends, and analysis. It encompasses a wealth of information regarding the industry's overview, growth patterns, demand dynamics, and global forecasts. Additionally, the report meticulously evaluates the competitive landscape, offering detailed profiles of key market players. Factors driving growth, market constraints, and recent industry developments are thoroughly examined within the report to…
Appylyf - Connect, communicate & collaborate
Appylyf is proud to announce the launch of its innovative communication and collaboration platform that is designed to streamline workflow and improve productivity for businesses and individuals alike.
"At Appylyf, we believe that communication and collaboration are the keys to success in today's fast-paced world," said Mr. Prabu P Kishore, The CEO of Appylyf.
"We created this platform to simplify the communication process, eliminate the need for multiple platforms, and ultimately help…
Connector Manufacturers Connect To Sensors
What functions do sensors perform? What applications utilize sensors? What are the fastest growing applications for electronic sensors?What is driving the interest in sensors by connector manufacturers? What advantages can connector manufacturers bring to the sensor market? What is the synergy between connectors and sensors?Who are the current leaders in the electronic sensor industry? What is the global market value of electronic sensors? What is the global market forecast for…
Connect with Concept Evolution…
Concept Connect from FSI (FM Solutions) Limited, Microsoft Gold partners, allows access to the Concept Evolution completely web-based Computer Aided Facilities Management (CAFM) solution to sub-contractors and those who do not require full system capability.
With Concept Connect, contractors and users can have a tailored version of Concept Evolution, giving them instant access to the information relevant to their contract, including Purchase Orders, Quotes, Task Management, Timesheets and Reports.
Features of Concept…
